Kiniksa Pharmaceuticals International, plc
Equities
KNSA
GB00BRXB0C07
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.36 USD | +1.36% | +3.70% | +10.38% |
01/07 | Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf | MT |
01/07 | Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) dropped from Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.38% | 137.62Cr | |
+16.61% | 12TCr | |
+17.75% | 11TCr | |
+17.23% | 2.59TCr | |
-24.11% | 1.93TCr | |
-18.56% | 1.62TCr | |
-18.47% | 1.56TCr | |
-47.75% | 1.46TCr | |
+57.35% | 1.43TCr | |
+5.62% | 1.4TCr |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals International, plc
- Wedbush Lowers Kiniksa Pharmaceuticals' Price Target to $20 From $26, Adjusts Commercial Ramp Assumptions for Arcalyst; Keeps Outperform Rating